The Future of DSHEA: Ensuring Balance, Research, and Market Access in Healthcare
On July 21, 2025, the Orrin G. Hatch Foundation hosted a timely and important conversation on the future of the Dietary Supplement Health and Education Act (DSHEA)—a landmark law that continues to shape the supplement industry and protect consumer access to health and wellness products. The panel—featuring Kyle Sampson (King & Spalding LLP), Steve Mister […]
Dietary Supplements, Drugs and DSHEA – Preserving DSHEA’s Careful Balance Between Market Access and Efficacy
By Matt SandgrenMatt is the executive director of the Orrin G. Hatch Foundation. A 15-year veteran of Capitol Hill, he served as senior counsel on the Senate Judiciary Committee and as Senator Hatch’s chief of staff. If, like millions of other Americans, you take a multivitamin, herbal supplement or omega-3 fatty acid (such as fish oil), you […]
Longevity Industry Faces Regulatory Challenges Over NMN
The Wall Street Journal reported on the booming longevity industry and the regulatory challenges faced by companies marketing NMN supplements. The article highlights the dispute between supplement companies and pharmaceutical firms over NMN’s classification and the FDA’s stance on its legality as a dietary supplement.
Court Grants Joint Motion to Stay NMN Lawsuit
A federal court granted a joint motion filed by the NPA and FDA to stay proceedings in the NMN lawsuit, pending the FDA’s response to the NPA’s citizen petition. The FDA indicated it would respond to the petition by July 31, 2025, and would not prioritize enforcement actions against NMN supplements in the interim.